Post Holdings (POST) Gains on Favorable Pricing & Brand Strength
https://www.zacks.com/stock/news/2257024/post-holdings-post-gains-on-favorable-pricing-brand-strength?cid=CS-ZC-FT-analyst_blog|rank_focused-2257024
Apr 17, 2024 - Post Holdings (POST) has been benefiting from strategic pricing actions undertaken to counter inflationary headwinds. Management is strengthening its business on the back of strategic acquisitions.
0
Clene stock rallies 52% post-market on MS drug data
https://seekingalpha.com/news/4090283-clene-stock-rallies-post-market-on-ms-drug-data?source=feed_sector_healthcare
Apr 16, 2024 - Clene (CLNN) stock rallied 52% post-market Tuesday after the company presented positive Phase 2 data for its drug CNM-Au8 in the treatment of multiple sclerosis. Read more here.
0
Align Technology (ALGN) to Post Q1 Earnings: What's in Store?
https://www.zacks.com/stock/news/2256315/align-technology-algn-to-post-q1-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2256315
Apr 16, 2024 - Align Technology's (ALGN) first-quarter 2024 performance is likely to reflect the strength of the Clear Aligner and Systems & Services businesses.
0
Netflix and United Airlines to report highest move post earnings: BofA
https://seekingalpha.com/news/4089597-bofa-picks-ppg-industries-netflix-and-united-airlines-for-options-opportunity-ahead-of-earnings?source=feed_sector_healthcare
Apr 15, 2024 - This article discusses a recent report from BoFA Securities on US equity options and positioning for potential earnings surprises.
0
Omnicom (OMC) to Post Q1 Earnings: What's in the Cards?
https://www.zacks.com/stock/news/2255559/omnicom-omc-to-post-q1-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2255559
Apr 15, 2024 - Omnicom's (OMC) first-quarter 2024 revenues are likely to have benefited from organic growth.
0
Badger Meter (BMI) to Post Q1 Earnings: Key Factors to Note
https://www.zacks.com/stock/news/2255415/badger-meter-bmi-to-post-q1-earnings-key-factors-to-note?cid=CS-ZC-FT-analyst_blog|earnings_preview-2255415
Apr 15, 2024 - Badger Meter's (BMI) first-quarter performance is likely to have benefited from robust demand across business segments.
0
Quest Diagnostics (DGX) to Post Q1 Earnings: What's in Store?
https://www.zacks.com/stock/news/2255306/quest-diagnostics-dgx-to-post-q1-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2255306
Apr 15, 2024 - Acquisitions and partnerships with health plans are expected to drive Quest Diagnostics' (DGX) base business performance in the first quarter of 2024.
0
Equifax (EFX) to Post Q1 Earnings: What's in the Offing?
https://www.zacks.com/stock/news/2254707/equifax-efx-to-post-q1-earnings-what-s-in-the-offing?cid=CS-ZC-FT-analyst_blog|earnings_preview-2254707
Apr 12, 2024 - Equifax's (EFX) first-quarter 2024 revenues are likely to have benefited from strong market penetration and growth in Latin America.
0
PACS Group: A Healthy Debut For This Post-Acute Care Provider
https://seekingalpha.com/article/4683413-pacs-group-a-healthy-debut-for-this-acute-care-provider?source=feed_tag_ipo_analysis
Apr 12, 2024 - PACS Group shares rose 10% on the first day of trading after its IPO. Read more to see my recommendation on PACS stock.
0
ALX Oncology (ALXO) Posts Upbeat Results From Lymphoma Study
https://www.zacks.com/stock/news/2253877/alx-oncology-alxo-posts-upbeat-results-from-lymphoma-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2253877
Apr 11, 2024 - ALX Oncology (ALXO) announces positive results from an early to mid-stage study of an investigational combination regimen to treat indolent and aggressive R/R B-NHL.
0